228 related articles for article (PubMed ID: 14734600)
1. Ranolazine and other antianginal therapies in the era of the drug-eluting stent.
Berger P
JAMA; 2004 Jan; 291(3):365-7. PubMed ID: 14734600
[No Abstract] [Full Text] [Related]
2. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
3. Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina.
Deedwania PC; Carbajal EV
Am J Med; 2011 Aug; 124(8):681-8. PubMed ID: 21787900
[TBL] [Abstract][Full Text] [Related]
4. Conventional and novel drug therapeutics to relief myocardial ischemia.
Dvir D; Battler A
Cardiovasc Drugs Ther; 2010 Aug; 24(4):319-23. PubMed ID: 20658184
[TBL] [Abstract][Full Text] [Related]
5. Metabolic management of ischaemic heart disease.
Chierchia SL; Fragasso G
Eur Heart J; 1993 Nov; 14 Suppl G():2-5. PubMed ID: 7904560
[TBL] [Abstract][Full Text] [Related]
6. Medical management of myocardial ischemia.
Sander GE; Giles TD
Am J Geriatr Cardiol; 2005; 14(4):205-9. PubMed ID: 16015063
[No Abstract] [Full Text] [Related]
7. Ranolazine as add-on therapy for patients with severe chronic angina.
Pechlaner C; Wiedermann C
JAMA; 2004 Apr; 291(16):1959; author reply 1959-60. PubMed ID: 15113811
[No Abstract] [Full Text] [Related]
8. Pharmacologic therapy of angina pectoris.
Zavecz JH; Bueno O
J La State Med Soc; 1995 May; 147(5):208-10, 213-6. PubMed ID: 7782675
[TBL] [Abstract][Full Text] [Related]
9. Ranolazine as add-on therapy for patients with severe chronic angina.
Hooper JS; Busti AJ
JAMA; 2004 Apr; 291(16):1959; author reply 1959-60. PubMed ID: 15113810
[No Abstract] [Full Text] [Related]
10. Ranolazine (Ranexa) for chronic stable angina.
Ndegwa S
Issues Emerg Health Technol; 2007 Jun; (99):1-6. PubMed ID: 17595750
[TBL] [Abstract][Full Text] [Related]
11. Utility of ranolazine in chronic stable angina patients.
Patel PD; Arora RR
Vasc Health Risk Manag; 2008; 4(4):819-24. PubMed ID: 19065998
[TBL] [Abstract][Full Text] [Related]
12. Trials and tribulations associated with angina and traditional therapeutic approaches.
Deedwania PC; Carbajal EV; Bobba VR
Clin Cardiol; 2007 Feb; 30(2 Suppl 1):I16-24. PubMed ID: 18373326
[TBL] [Abstract][Full Text] [Related]
13. Does ranolazine have a place in the treatment of acute coronary syndromes?
Newby LK; Peterson ED
JAMA; 2007 Apr; 297(16):1823-5. PubMed ID: 17456825
[No Abstract] [Full Text] [Related]
14. Ranolazine: a review of its use in chronic stable angina pectoris.
Siddiqui MA; Keam SJ
Drugs; 2006; 66(5):693-710. PubMed ID: 16620147
[TBL] [Abstract][Full Text] [Related]
15. Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study.
Melloni C; Newby LK
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):9-16. PubMed ID: 18095903
[TBL] [Abstract][Full Text] [Related]
16. Impact of ranolazine on clinical outcomes and healthcare resource utilization in patients with refractory angina pectoris.
Ling H; Packard KA; Burns TL; Hilleman DE
Am J Cardiovasc Drugs; 2013 Dec; 13(6):407-12. PubMed ID: 23873327
[TBL] [Abstract][Full Text] [Related]
17. Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem.
Cocco G; Rousseau MF; Bouvy T; Cheron P; Williams G; Detry JM; Pouleur H
J Cardiovasc Pharmacol; 1992 Jul; 20(1):131-8. PubMed ID: 1383622
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
Rousseau MF; Pouleur H; Cocco G; Wolff AA
Am J Cardiol; 2005 Feb; 95(3):311-6. PubMed ID: 15670536
[TBL] [Abstract][Full Text] [Related]
19. Use of ranolazine in patients with stable angina pectoris.
Khera S; Kolte D; Aronow WS
Cardiology; 2014; 128(3):251-8. PubMed ID: 24852049
[TBL] [Abstract][Full Text] [Related]
20. Measuring antianginal drug efficacy using exercise testing for chronic angina: improved exercise performance with ranolazine, a pFOX inhibitor.
Chaitman BR
Curr Probl Cardiol; 2002 Dec; 27(12):527-55. PubMed ID: 12501118
[No Abstract] [Full Text] [Related]
[Next] [New Search]